These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 17638891

  • 1. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.
    Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG.
    Cancer Res; 2007 Jul 15; 67(14):6796-805. PubMed ID: 17638891
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.
    Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG.
    Oncogene; 2006 Mar 16; 25(12):1696-708. PubMed ID: 16449977
    [Abstract] [Full Text] [Related]

  • 4. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
    Rowehl RA, Crawford H, Dufour A, Ju J, Botchkina GI.
    Cancer Genomics Proteomics; 2008 Mar 16; 5(6):301-10. PubMed ID: 19287071
    [Abstract] [Full Text] [Related]

  • 5. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
    Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, Masumori N, Tsukamoto T, Sato N.
    J Urol; 2012 Jul 16; 188(1):294-9. PubMed ID: 22608744
    [Abstract] [Full Text] [Related]

  • 6. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.
    Yu C, Yao Z, Dai J, Zhang H, Escara-Wilke J, Zhang X, Keller ET.
    In Vivo; 2011 Jul 16; 25(1):69-76. PubMed ID: 21282737
    [Abstract] [Full Text] [Related]

  • 7. Prostate cancer stem/progenitor cells: identification, characterization, and implications.
    Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, Schneider-Broussard R, Jeter C.
    Mol Carcinog; 2007 Jan 16; 46(1):1-14. PubMed ID: 16921491
    [Abstract] [Full Text] [Related]

  • 8. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
    Palapattu GS, Wu C, Silvers CR, Martin HB, Williams K, Salamone L, Bushnell T, Huang LS, Yang Q, Huang J.
    Prostate; 2009 May 15; 69(7):787-98. PubMed ID: 19189306
    [Abstract] [Full Text] [Related]

  • 9. Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.
    Chauchereau A, Al Nakouzi N, Gaudin C, Le Moulec S, Compagno D, Auger N, Bénard J, Opolon P, Rozet F, Validire P, Fromont G, Fizazi K.
    Exp Cell Res; 2011 Feb 01; 317(3):262-75. PubMed ID: 20974126
    [Abstract] [Full Text] [Related]

  • 10. Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.
    Li H, Zhou J, Miki J, Furusato B, Gu Y, Srivastava S, McLeod DG, Vogel JC, Rhim JS.
    Exp Cell Res; 2008 Jan 01; 314(1):92-102. PubMed ID: 17900565
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Proteomic analysis of cancer stem cells in human prostate cancer cells.
    Lee EK, Cho H, Kim CW.
    Biochem Biophys Res Commun; 2011 Aug 26; 412(2):279-85. PubMed ID: 21820414
    [Abstract] [Full Text] [Related]

  • 14. Characterization of a subpopulation of colon cancer cells with stem cell-like properties.
    Chu P, Clanton DJ, Snipas TS, Lee J, Mitchell E, Nguyen ML, Hare E, Peach RJ.
    Int J Cancer; 2009 Mar 15; 124(6):1312-21. PubMed ID: 19072981
    [Abstract] [Full Text] [Related]

  • 15. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG, Gardner WA.
    Med Hypotheses; 2008 Mar 15; 70(2):387-408. PubMed ID: 17658698
    [Abstract] [Full Text] [Related]

  • 16. Potent oncolytic activity of human enteroviruses against human prostate cancer.
    Berry LJ, Au GG, Barry RD, Shafren DR.
    Prostate; 2008 May 01; 68(6):577-87. PubMed ID: 18288643
    [Abstract] [Full Text] [Related]

  • 17. CD44 as a molecular marker to screen cancer stem cells in hypopharyngeal cancer.
    Shen C, Xiang M, Nie C, Hu H, Ma Y, Wu H.
    Acta Otolaryngol; 2013 Nov 01; 133(11):1219-26. PubMed ID: 23837451
    [Abstract] [Full Text] [Related]

  • 18. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S, Lee J, Revelo M, Wang X, Lu S, Dong Z.
    Clin Cancer Res; 2007 Oct 01; 13(19):5692-702. PubMed ID: 17908958
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.